Four Seasons
San Francisco, CA
Wilson Sonsini is proud to sponsor the Longwood Healthcare Leaders San Francisco CEO meeting.
Longwood Healthcare Leaders San Francisco CEO brings together leading biopharma CEOs, heads of R&D, top academic researchers, and life science investors the weekend prior to the JP Morgan Healthcare Conference for off-the-record discussion, held at the Four Seasons San Francisco. The industry-leading meeting focuses on a broad spectrum of topics affecting the biopharma ecosystem.
On Saturday, January 10th at 1:35pm PT, partner Maya Skubatch will moderate the panel session, "Health Equity and Ensuring Access to Innovation," alongside fellow panelists, Julian Adams, CEO of Stand Up to Cancer; Sabrina Johnson, CEO of Daré Bioscience; Liz Thompson, EVP, R&D of Acadia; and Greg Tietjen, CEO, Revalia Bio.
The agenda has been developed to maximize efficient networking opportunities, including luncheons, breakfasts, and a cocktail reception on Saturday, January 10, following the first day of panels for registered participants. To learn more, visit www.longwoodhealthcareleaders.com/sfceo.
Longwood Healthcare Leaders hosts thought leaders, key executives, and government officials for quarterly forums. These meetings aim to foster collaboration, exchange insights, and drive biomedical advancements from the top, facilitating discussions that promote transparency and collaboration among participants with the goal of accelerating the translation of discoveries into medicines that can improve patient outcomes. For more information, visit www.longwoodhealthcareleaders.com.
Katie Stonum
kstonum@wsgr.com
Maya Skubatch was a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati and a former member of the firm’s board of directors. Maya focused on strategic patent counseling for both private and public life science companies. She worked closely with licensing, litigation, corporate, and regulatory counsel to provide integrated IP strategies and often assists clients with intellectual property matters pertaining to financings, M&A, and partnership deals. Maya also worked with investors on IP diligence matters.